4D Molecular Therapeutics, Inc. (FDMT)
NMS – Real Time Price. Currency in USD
11.60
+0.08 (0.69%)
At close: Jun 26, 2026, 4:00 PM EDT
11.37
-0.23 (-1.98%)
After-hours: Jun 26, 2026, 6:03 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
11.60
+0.08 (0.69%)
At close: Jun 26, 2026, 4:00 PM EDT
11.37
-0.23 (-1.98%)
After-hours: Jun 26, 2026, 6:03 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $72.5M significantly exceed its total debt $20.5M, ensuring strong financial flexibility
Total current assets $405.4M exceed Total current liabilities $43.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$68.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.34 | 6.05 | 10 | |
| Quick ratio | 9.34 | 5.63 | 10 | |
| Debt to Equity | 0.05 | 0.30 | 9.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 21M | 37K | 85M | 88M |
| Gross Profit | -751K | 15M | -7M | 78M | 80M |
| Operating Income | -110M | -113M | -188M | -160M | -180M |
| Net Income | -107M | -101M | -161M | -140M | -161M |
| EBITDA | -106M | -107M | -181M | -152M | -172M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 17633.33 | 1.02 | 6.5 |
| Next quarter | 2919.05 | 3.85 | 7.0 |
| Current year | -87.24 | -60.7 | 1.0 |
| Next year | 39.57 | 4.25 | 7.0 |
| Weighted average score | 5.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -96.41 | -454.48 | -334.87 | -338.01 | 1.0 |
| Y/Y | 21664.29 | -43.32 | -17.43 | -40.78 | 3.3 |
| 3y average | 76885.69 | -13.47 | 8.53 | -11.77 | 4.5 |
| 5y average | 46121.39 | -23.38 | 13.46 | -22.3 | 5.0 |
| Weighted average score | 3.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |